1. Third-line therapy for metastatic colorectal cancer

   • M. G. Gundgaard
   • J. B. Soerensen
   • E. Ehrnrooth

   Review 05 September 2007 Pages: 1 - 13

   

2. Modification of multidrug resistance of tumor cells by ionizing radiation

   • Yuri N. Korystov
   • Vera V. Shaposhnikova
   • Ludmila N. Kublik

   Original Article 14 March 2007 Pages: 15 - 21

   

3. The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers

   • Rob J. Jones
   • Tamsin Boyce
   • John Robertson

   Original Article 20 March 2007 Pages: 23 - 32

   

4. Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy

   • Li Zhang
   • Yang Zhang
   • Zhong-Zhen Guan

   Original Article 20 March 2007 Pages: 33 - 38

   

5. A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin

   • Alfred F. Furth
   • Sumithra J. Mandrekar
   • Joel M. Reid

   Original Article 20 March 2007 Pages: 39 - 45

   

6. Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

   • Jeeyun Lee
   • Tae-You Kim
   • on behalf of the Korean Cancer Study Group

   Original Article 16 March 2007 Pages: 47 - 52

   

7. Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer

   • Yoshihiro Wada
   • Ken Kikuchi
   • Shoichi Ueda

   Original Article 21 March 2007 Pages: 53 - 61

   

8. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate

   • Lee Jia
   • Lori C. Coward
   • John C. Reed

   Original Article 14 March 2007 Pages: 63 - 73

   

9. The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer

   • Sang Joon Shin
   • Joong Bae Ahn
   • Jae Kyung Roh

   Original Article 21 March 2007 Pages: 75 - 81

   

10. A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus

    • Dae Ho Lee
    • Heung Tae Kim
    • Jin Soo Lee

    Original Article 28 April 2007 Pages: 83 - 88

    

11. Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice

    • Roni Haklai
    • Galit Elad-Sfadia
    • Yoel Kloog

    Original Article 20 March 2007 Pages: 89 - 96

    

12. Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction

    • Martina Baur
    • Anne Drescher
    • Ulrich Jaehde

    Original Article 30 March 2007 Pages: 97 - 104

    

13. Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin

    • Roberto Petrioli
    • Alessandra Pascucci
    • Guido Francini

    Original Article 12 April 2007 Pages: 105 - 111

    

14. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring

    • G. Vassal
    • G. Michel
    • C. Puozzo

    Original Article 29 March 2007 Pages: 113 - 123

    

15. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer

    • T. O’Connor
    • Y. Rustum
    • P. Creaven

    Original Article 11 April 2007 Pages: 125 - 131

16. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(ε-caprolactone) micelles of rapamycin

    • Jaime A. Yáñez
    • M. Laird Forrest
    • Neal M. Davies

    Original Article 29 March 2007 Pages: 133 - 144

    

17. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria

    • N. A. G. Santos
    • C. S. Catão Bezerra
    • A. C. Santos

    Original Article 30 March 2007 Pages: 145 - 155

    

18. Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer

    • Sang Joon Shin
    • Hei-Cheul Jeung
    • Hyun Cheol Chung

    Original Article 11 April 2007 Pages: 157 - 165

    

19. The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis

    • Robert L. Fine
    • David R. Fogelman
    • John Chabot

    Clinical Trial Report 18 April 2007 Pages: 167 - 175

    

20. The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis

    • Robert L. Fine
    • David R. Fogelman
    • John Chabot

    Erratum 09 September 2007 Pages: 177 - 177